SCHEMBL18907412

SCHEMBL18907412

c1ccc2c(c1)ccc1c3ccc4ccccc4c3c(-c3c4ccccc4c(-c4ccncc4)c4ccccc34)nc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 3/20 0.37
CYP1A1 P04798 2/20 0.37
POLB P06746 2/20 0.37
CYP1B1 Q16678 2/20 0.37
CFTR P13569 1/20 0.37
MAPK8 P45983 1/20 0.36
MAPK9 P45984 1/20 0.36
MAPK10 P53779 1/20 0.36
RAB9A P51151 4/20 0.36
MAPK1 P28482 3/20 0.36
CYP3A4 P08684 2/20 0.36
HSD17B10 Q99714 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907289 0.89 MAPT (0.40) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL18907348 0.84 MAPK10 (0.41) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL18907332 0.83 MAPT (0.49) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL18907421 0.82 ESR1 (0.46) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL15004434 0.81 CYP1A2 (0.44) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL18907322 0.81 KDM4E (0.32) MAPTHPGDKDM4EALDH1A1
SCHEMBL18907240 0.78 MAPT (0.43) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL18907214 0.74 KDM4E (0.47) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL12014499 0.72 KDM4E (0.50) MAPTHPGDKDM4EALDH1A1CYP1A2
SCHEMBL18907414 0.72 MAPT (0.50) MAPTHPGDKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 MAPT 2043/4885HPGD 1753/4885KDM4E 2914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.